Get started
Author

Laura Salinas-Ortega

Observed names: L Salinas-Ortega, L. Salinas-Ortega, Salinas-Ortega, Laura
ORCID: 0000-0002-7066-0659
Observed ORCID: 0000-0002-7066-0659
OpenAlex ID: A5043795675
The economic impact of anastomotic leak after colorectal cancer surgery
2023 · Blas Flor-Lorente, José Francisco Noguera-Aguilar, et al. · Health Economics Review · 28
PDF
Budget impact analysis of bevacizumab biosimilars for cancer treatment in adult patients in Spain
2021 · Miguel Angel Calleja, Joan Albanell, et al. · European Journal of Hospital Pharmacy · 17
PDF
Assessing the economic burden of vision loss and irreversible legal blindness in Spain (2021–2030): a societal perspective
2024 · Luis Pablo, Gonzaga Garay-Aramburu, et al. · Health Economics Review · 16
PDF
Cost-Effectiveness of Lorlatinib for the Treatment of Adult Patients with Anaplastic Lymphoma Kinase Positive Advanced Non-Small Cell Lung Cancer in Spain
2023 · María Presa, David Vicente, et al. · ClinicoEconomics and Outcomes Research · 9
PDF
Cost analysis of hidden hepatitis D virus infection in Spain
2025 · Xavier Forns, Manuel Rodríguez, et al. · Gastroenterología y Hepatología · 4
The efficiency of artificial intelligence for management and clinical decision-making in the identification of patients with hidden HCV infection (Intelligen-C strategy)
2025 · José Luis Castro Urda, Marta Álvarez, et al. · Gastroenterología y Hepatología · 3
Análisis de los costes asociados a la administración intramuscular versus oral de la terapia antirretroviral en el manejo de la infección por el virus de la inmunodeficiencia humana
2024 · Vicente Estrada, Juan Emilio Losa, et al. · Enfermedades Infecciosas y Microbiología Clínica · 2
#1672 Cost-effectiveness analysis of voclosporin vs mycophenolate or belimumab in the treatment of patients with lupus nephritis from the Spanish National Healthcare System perspective
2025 · Nuria Paladio Duran, Laura Salinas-Ortega, et al. · Nephrology Dialysis Transplantation · 1
PDF
Cost analysis associated with intramuscular versus oral administration of antiretroviral therapy in the management of human immunodeficiency virus infection
2024 · Vicente Estrada, Juan Emilio Losa, et al. · Enfermedades infecciosas y microbiologia clinica (English ed ) · 1
Estrategia de detección precoz de hepatitis víricas en pacientes con solicitud de perfil bioquímico hepático e hipertransaminasemia
2024 · P. Tajada Alegre, V. Villalta Robles, et al. · Medicina de Familia SEMERGEN · 1
Short-term economic impact of early leaks after metabolic bariatric surgery
2026 · José M Balibrea, Javier Osorio, et al. · British journal of surgery
O-152 - Carga Económica De La Fuga Tras Cirugía Bariátrica En España
2025 · José María Balibrea, Javier Osorio, et al. · Cirugía Española
The efficiency of artificial intelligence for management and clinical decision-making in the identification of patients with hidden HCV infection (Intelligen-C strategy)
2025 · José Luis Castro Urda, Marta Álvarez, et al. · Gastroenterología y Hepatología (English Edition)
EE193 Lorlatinib as a First-Line Treatment for ALK+ Advanced Non-Small Cell Lung Cancer: A Cost-Effectiveness Analysis in Spain
2022 · M Presa, D Vicente, et al. · Value in Health
PDF
Works count: 18
Citation count: 82
H-index: 4
I10-index: 3
Year
Topic
Type